智通财经APP讯，中国心连心化肥(01866)公布2025年中期业绩，收入约126.66亿元，同比增长约5%;母公司拥有人应占溢利约5.99亿元，同比减少12.77%;基本每股盈利51.50分。
上半年，尽管原料成本有所下滑，但受供需失衡等因素影响，产品的售价降幅超过了成本降幅，致使整体毛利同比下降13%。其中，尿素产品受售价下滑拖累，其毛利同比降幅近44%，成为拉低集团整体毛利的主要原因。受此影响净利下降。
从第二季度单季业绩表现来看，各产品售价均呈显著向好态势，其中，尿素及三聚氰胺表现突出，其售价环比分别增长10%和11%。此外，得益于销售网络的持续密植，复合肥及三聚氰胺的销量环比分别增长29%和20%。在售价与销量的双重向好推动下，第二季度毛利环比提升44%，有效带动集团第二季度净利润环比增长约2.59亿元，增幅高达104%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.